Furthermore, high CLEC11A expression was significantly linked to unfavorable OS for GC patients, considering factors, such as Lauren classification, differentiation, and human epidermal growth factor receptor 2 (HER2) status. The gene discussed is ERBB2; the disease is gastric cancer.